1. Home
  2. STKH vs NLSP Comparison

STKH vs NLSP Comparison

Compare STKH & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • NLSP
  • Stock Information
  • Founded
  • STKH 2018
  • NLSP 2015
  • Country
  • STKH Israel
  • NLSP Switzerland
  • Employees
  • STKH N/A
  • NLSP N/A
  • Industry
  • STKH Packaged Foods
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKH Consumer Staples
  • NLSP Health Care
  • Exchange
  • STKH Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • STKH 4.9M
  • NLSP 5.8M
  • IPO Year
  • STKH 2021
  • NLSP 2021
  • Fundamental
  • Price
  • STKH $2.44
  • NLSP $2.30
  • Analyst Decision
  • STKH
  • NLSP
  • Analyst Count
  • STKH 0
  • NLSP 0
  • Target Price
  • STKH N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • STKH 96.1K
  • NLSP 423.9K
  • Earning Date
  • STKH 03-31-2025
  • NLSP 06-17-2025
  • Dividend Yield
  • STKH N/A
  • NLSP N/A
  • EPS Growth
  • STKH N/A
  • NLSP N/A
  • EPS
  • STKH N/A
  • NLSP N/A
  • Revenue
  • STKH $10,000.00
  • NLSP N/A
  • Revenue This Year
  • STKH N/A
  • NLSP N/A
  • Revenue Next Year
  • STKH N/A
  • NLSP N/A
  • P/E Ratio
  • STKH N/A
  • NLSP N/A
  • Revenue Growth
  • STKH N/A
  • NLSP N/A
  • 52 Week Low
  • STKH $2.12
  • NLSP $1.30
  • 52 Week High
  • STKH $21.33
  • NLSP $18.39
  • Technical
  • Relative Strength Index (RSI)
  • STKH 36.29
  • NLSP 65.15
  • Support Level
  • STKH $2.12
  • NLSP $1.58
  • Resistance Level
  • STKH $2.47
  • NLSP $2.39
  • Average True Range (ATR)
  • STKH 0.21
  • NLSP 0.23
  • MACD
  • STKH 0.03
  • NLSP 0.02
  • Stochastic Oscillator
  • STKH 30.72
  • NLSP 89.29

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: